Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001477932-24-001475
Filing Date
2024-03-27
Accepted
2024-03-26 18:44:38
Documents
18
Period of Report
2024-03-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A thct_8ka.htm   iXBRL 8-K/A 24795
2 LETTER thct_ex161.htm EX-16.1 4622
8 thct_ex161img2.jpg GRAPHIC 2710
9 thct_ex161img3.jpg GRAPHIC 4643
  Complete submission text file 0001477932-24-001475.txt   156956

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA thct-20240308.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20240308_lab.xml EX-101.LAB 13138
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20240308_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20240308_pre.xml EX-101.PRE 8234
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20240308_def.xml EX-101.DEF 2099
21 EXTRACTED XBRL INSTANCE DOCUMENT thct_8ka_htm.xml XML 3988
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 000-55994 | Film No.: 24785223
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)